101. 3D-ink-extruded titanium scaffolds with porous struts and bioactive supramolecular polymers for orthopedic implants.
- Author
-
Misiaszek JP, Sather NA, Goodwin AM, Brecount HJ, Kurapaty SS, Inglis JE, Hsu EL, Stupp SI, Stock SR, and Dunand DC
- Subjects
- Animals, Porosity, Printing, Three-Dimensional, Polymers chemistry, Polymers pharmacology, Rats, Prostheses and Implants, X-Ray Microtomography, Recombinant Proteins pharmacology, Humans, Transforming Growth Factor beta, Titanium chemistry, Titanium pharmacology, Tissue Scaffolds chemistry, Bone Morphogenetic Protein 2 pharmacology, Bone Morphogenetic Protein 2 chemistry, Rats, Sprague-Dawley
- Abstract
Porous titanium addresses the longstanding orthopedic challenges of aseptic loosening and stress shielding. This work expands on the evolution of porous Ti with the manufacturing of hierarchically porous, low stiffness, ductile Ti scaffolds via direct-ink write (DIW) extrusion and sintering of inks containing Ti and NaCl particles. Scaffold macrochannels were filled with a subtherapeutic dose of recombinant bone morphogenetic protein-2 (rhBMP-2) alone or co-delivered within a bioactive supramolecular polymer slurry (SPS) composed of peptide amphiphile nanofibrils and collagen, creating four treatment conditions (Ti struts: microporous vs. fully dense; BMP-2 alone or with SPS). The BMP-2-loaded scaffolds were implanted bilaterally across the L4 and L5 transverse processes in a rat posterolateral lumbar fusion model. In-vivo bone growth in these scaffolds is evaluated with synchrotron X-ray computed microtomography (µCT) to study the effects of strut microporosity and added biological signaling agents on the bone formation response. Optical and scanning electron microscopy confirms the ∼100 µm space-holder micropore size, high-curvature morphology, and pore fenestrations within the struts. Uniaxial compression testing shows that the microporous strut scaffolds have low stiffness and high ductility. A significant promotion in bone formation was observed for groups utilizing the SPS, while no significant differences were found for the scaffolds with the incorporation of micropores. STATEMENT OF SIGNIFICANCE: By 2050, the anticipated number of people aged 60 years and older worldwide is anticipated to double to 2.1 billion. This rapid increase in the geriatric population will require a corresponding increase in orthopedic surgeries and more effective materials for longer indwelling times. Titanium alloys have been the gold standard of bone fusion and fixation, but their use has longstanding limitations in bone-implant stiffness mismatch and insufficient osseointegration. We utilize 3D-printing of titanium with NaCl space holders for large- and small-scale porosity and incorporate bioactive supramolecular polymers into the scaffolds to increase bone growth. This work finds no significant change in bone ingrowth via space-holder-induced microporosity but significant increases in bone ingrowth via the bioactive supramolecular polymers in a rat posterolateral fusion model., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: DCD maintains a financial interest in Metalprinting, Inc. (South Korea) which is active in ink-based materials printing. SIS, NAS, and ELH report a relationship with Amphix Bio that includes equity or stocks. SIS and ELH are inventors on patent #US20170106120A1 issued to Northwestern University., (Copyright © 2024 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF